Pressure Mounts on Health Plans as Vaccine Panel Makes Shift

Health insurers are still planning to cover the hepatitis B vaccine at no cost to patients after the Centers for Disease Control and Prevention’s advisory panel voted to narrow its recommendations, but it’s unclear whether employers will follow suit.

Blue States Push Back Against Hepatitis B Vaccine Advice Changes

States and cities led by Democrats are balking at US vaccine advisers’ calls to no longer require all babies get hepatitis B vaccines within 24 hours of being born, portraying the recommendation as troubling and at odds with scientific consensus.

FDA Slow Walking a Long-Awaited Abortion Pill Safety Study

The Food and Drug Administration has delayed a promised review of safety data for the abortion drug mifepristone at Commissioner Marty Makary’s request to put it off until after the midterm elections, according to people familiar with the matter.

Senate GOP Floats Health Plans as Credits Near Expiration

Senate Republicans are putting out their own ideas to lower health care costs as Obamacare enrollees brace for an increase in premium payments next year.

A protester holds a sign in support of gender-affirming care for transgender youth outside of the US Supreme Court Building in Washington, DC. Advocates organized a rally in response the U.S. Supreme Court’s ruling in US v. Skrmetti, in which the justices ruled to uphold state bans on gender-affirming medical care for transgender youth. (Photo by Anna Moneymaker/Getty Images)

Fate of West Virginia Trans Care Medicaid Ban Tied to Skrmetti

Transgender individuals’ health-care rights will come under judicial scrutiny Tuesday, as a federal appeals court panel will hear arguments that center on the application of a recent US Supreme Court decision to West Virginia’s exclusion of “transsexual surgery” from Medicaid coverage.

Latest Stories

FDA Slow Walking a Long-Awaited Abortion Pill Safety Study

The Food and Drug Administration has delayed a promised review of safety data for the abortion drug mifepristone at Commissioner Marty Makary’s request to put it off until after the midterm elections, according to people familiar with the matter.

Kaiser Agrees to $47.5 Million Settlement in Data-Sharing Suit

Kaiser Foundation Health Plan would pay up to $47.5 million to settle a lawsuit alleging it disclosed patients’ personal information to Google LLC, Microsoft Corp., and other tech providers without consent in violation of state wiretapping laws, under a deal given initial approval in federal court.

Fate of West Virginia Trans Care Medicaid Ban Tied to Skrmetti

Transgender individuals’ health-care rights will come under judicial scrutiny Tuesday, as a federal appeals court panel will hear arguments that center on the application of a recent US Supreme Court decision to West Virginia’s exclusion of “transsexual surgery” from Medicaid coverage.

Beyond Abortion: The Fight Over Fetal Personhood Is Here

When do legal rights begin, at birth or before that? This video looks at the fetal personhood movement, and what it could mean for the future of abortion. We explore its history and the constitutional argument underpinning it.

From Across Bloomberg Law

Business & PracticeEnvironment & EnergyEnvironmental, Social & Governance (ESG)The United States Law Week
  • Business & Practice
  • Environment & Energy
  • Environmental, Social & Governance (ESG)
  • The United States Law Week

Covid Vaccine & Personal Data: Does HIPAA Still Matter?

EXPLORE BLOOMBERG LAW

Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas: